NEURODERMATITIS
Clinical trials for NEURODERMATITIS explained in plain language.
Never miss a new study
Get alerted when new NEURODERMATITIS trials appear
Sign up with your email to follow new studies for NEURODERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot could tame uncontrollable itch of prurigo nodularis
Disease control CompletedThis study tested the drug dupilumab in 151 adults with prurigo nodularis, a condition causing intense itching and raised skin bumps. Participants had severe itch that creams could not control. They received either dupilumab injections or a placebo for 24 weeks. The main goal was…
Matched conditions: NEURODERMATITIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 18:24 UTC
-
New hope for chronic itch: dupilumab tackles prurigo nodularis
Disease control CompletedThis study tested the drug dupilumab in 160 adults with prurigo nodularis, a skin condition causing intense itching and bumps. Participants received either dupilumab injections or a placebo for up to 24 weeks. The main goal was to see if dupilumab could reduce itch by at least 4 …
Matched conditions: NEURODERMATITIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 17:54 UTC
-
Shockwave therapy shows promise for relieving neurodermatitis itch
Symptom relief CompletedThis study tested whether extracorporeal shockwave therapy (ESWT) can reduce itching in people with neurodermatitis. Thirty-four adults aged 55 to 75 received four weekly sessions of shockwaves applied to the skin. The main goal was to measure changes in itch severity using a sta…
Matched conditions: NEURODERMATITIS
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC